Reversing oliguria in critically ill patients

Postgraduate Medicine

Volumn 102, Issue 3, 1997, Pages 245-263

  DePriest, Jack ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BUMETANIDE; DOPAMINE; FUROSEMIDE; LOOP DIURETIC AGENT; MANNITOL; METOLAZONE; THIAZIDE DIURETIC AGENT;

ARTICLE; BLOOD FILTRATION; CRITICAL ILLNESS; DRUG EFFECT; FLUID INTAKE; HEMOFILTRATION; HUMAN; OLIGURIA; OTOTOXICITY;

EID: 0030987586     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.09.324     Document Type: Article

References (20)

1. Dixon BS, Anderson RJ. Nonoliguric acute renal failure. Am J Kidney Dis 1985; 6(2):71-80
2. Zaloga GP, Hughes SS. Oliguria in patients with normal renal function. Anesthesiology 1990;72(4):598-602
3. French Study Group on Acute Renal Failure. Acute renal failure in intensive care units - causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. Crit Care Med 1996;24(2):192-8
4. Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol 1981;15(2):90-6
5. Cohen AJ. Use of diuretics in the intensive care unit. In: Rippe JM, Irwin JM, Alpert JS, et al, eds. Intensive care medicine. 2d ed. Boston: Little, Brown, 1991:735-7
6. Puschett JB. Clinical pharmacologic implications in diuretic selection. Am J Cardiol 1986;57(2):6-13A
7. Bersten AD, Holt AW. Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995;3(4):650-61
8. Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989;17(5):426-9
9. van Meyel JJ, Smits P, Russel FG, et al. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther 1992;51(4):440-4
10. Martin SJ, Danziger LH. Continuous infusion of loop diuretics in the critically ill: a review of the literature. Crit Care Med 1994;22(8):1323-9
11. Graziani G, Cantaluppi A, Casati S, et al. Dopamine and frusemide in oliguric acute renal failure. Nephron 1984;37(1): 39-42
12. Rybak LP. Ototoxicity of loop diuretics. Otolaryngol Clin North Am 1993; 26(5):829-44
13. Brater DC. Disposition and response to bumetanide and furosemide. Am J Cardiol 1986;57(2):20-5A
14. Wollam GL, Tarazi RC, Bravo EL, et al. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med 1982; 72(6):929-38
15. Vincent JL. Renal effects of dopamine: can our dream ever come true? (Editorial) Crit Care Med 1994;22(1):5-6
16. Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994;22(1):61-6
17. Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 1994;22(12):1919-25
18. Inoue M, Okajima K, Itoh K, et al. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 1987;32(2):198-203
19. Ronco C, Barbacini S, Digito A, et al. Achievements and new directions in continuous renal replacement therapies. New Horiz 1995;3(4):708-16
20. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993;21(3):328-38